Generative AI in Healthcare Market to Reach $30.68B by 2033, Growing at 35.1% CAGR | DataM Intelligence

AUSTIN, TX, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- Generative AI in Healthcare Market Size reached US$ 2.92 Billion in 2024 and is expected to reach US$ 30.68 Billion by 2033, growing at a CAGR of 35.1% during the forecast period 2025-2033. This impressive growth trajectory reflects the industry’s rapid adoption of cutting-edge AI models to transform everything from clinical decision-making and diagnostics to administrative workflows and drug discovery.

The healthcare sector is experiencing a major transformation driven by the emergence of generative AI tools that can process and generate human-like text, images, and even molecular designs. In hospitals, AI chatbots and virtual assistants now help triage patients, answer questions, and even manage appointments. In clinical research, large-language models (LLMs) are accelerating literature reviews, while image-generation tools aid radiologists by enhancing the interpretation of complex imaging data.

To Download Sample Report: https://datamintelligence.com/download-sample/generative-ai-in-healthcare-market

Recent Developments:

In December 2024, DexCom, Inc. introduced its proprietary Generative AI (GenAI) platform, becoming the first CGM manufacturer to integrate GenAI with glucose biosensing. The platform uses advanced AI to analyze individual health patterns, connecting lifestyle factors with glucose levels and offering actionable insights for better metabolic health.

In October 2024, Microsoft expanded its Cloud for Healthcare offerings, launching multiple AI-driven enhancements. These advancements feature new healthcare AI models in Azure AI Studio, enhanced data capabilities through Microsoft Fabric, and updated developer tools in Copilot Studio all designed to improve healthcare outcomes.

In June 2024, Cognizant introduced its first healthcare-focused Large Language Model (LLM) suite, developed in collaboration with Google Cloud, leveraging generative AI technologies such as Vertex AI and Gemini to advance healthcare solutions.

In March 2024, NVIDIA Healthcare released a new suite of generative AI microservices to accelerate innovation in drug discovery, MedTech, and digital health. The launch includes 25 new cloud-agnostic microservices designed for applications in biology, chemistry, medical imaging, and healthcare data management.

Regional Outlook

North America remains the largest regional market for generative AI in healthcare, accounting for nearly half of global revenues. The U.S. leads the way with strong investments from both private technology companies and public-sector agencies. American healthcare providers are increasingly embedding generative AI solutions into clinical practice, supported by evolving regulatory frameworks.

The Asia-Pacific region is experiencing the fastest growth, driven primarily by Japan, China, and India. In Japan, a tech-savvy population, strong government support, and an aging demographic are driving demand for AI solutions that can help manage chronic diseases and mitigate healthcare workforce shortages. China is investing heavily in AI healthcare startups and infrastructure, while India is seeing the emergence of cost-effective, AI-powered healthtech platforms aimed at expanding access to care.

Europe is also making significant strides, with the European Union focusing on harmonizing AI standards across member states to enable safe and effective deployment in healthcare settings.

Companies and Industry Landscape

Google LLC

Microsoft

OpenAI

NVIDIA Corporation

Oracle

Johnson & Johnson Services, Inc.

NioyaTech.

Saxon.

Market Segmentation:

By Component: Solutions, Services.

By Application: Diagnostics & Medical Imaging, Personalized Treatment,Drug Discovery & Development, Patient Monitoring & Predictive Analytics, Others.

By End-User: Hospitals & Clinics, Healthcare Organizations, Diagnostic Centers, Others.

By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Latest News: USA

In the U.S., the FDA is accelerating efforts to integrate generative AI, aiming to deploy AI tools across all its centers by mid-2025 to streamline drug, device, and diagnostic reviews building on successful pilot programs that speed up regulatory document analysis. At the same time, over 80% of hospital executives expect AI to significantly impact clinical workflows within a year, with AI assistants now generating patient summaries, suggesting treatments, and aiding in diagnostic imaging.

Prominent collaborations are further shaping this landscape: Google and Mayo Clinic are developing enterprise-level AI search tools for clinicians, while startups like Suki offer AI-powered voice assistants to ease doctors’ administrative load and reduce burnout. Meanwhile, Washington is advancing new guidelines around AI transparency, data privacy, and algorithmic bias to ensure innovation proceeds with patient safety in mind.

Latest News: Japan

Japan is emerging as a key player in generative AI healthcare. The country’s first patient-facing generative AI agent developed by Hippocratic AI and EUCALIA now supports appointment scheduling, medication reminders, and post-discharge follow-ups, addressing care gaps caused by Japan’s aging population and shrinking healthcare workforce. Meanwhile, the government’s new voluntary guidelines for ethical AI use in healthcare are setting a model for balancing innovation with public trust, emphasizing patient privacy, transparency, and human oversight.

On the research side, Japan’s Cabinet Office launched a healthcare-specific large-language model in early 2025 to assist clinical decision-making with localized Japanese data. Academic and industry collaborations are also advancing AI-driven drug discovery through next-gen AI platforms. As debates continue on privacy standards for pseudonymized health and genomic data, policymakers aim to create frameworks that both protect patient rights and support AI innovation.

Outlook

The future of generative AI in healthcare is bright. Driven by breakthroughs in model capabilities, increasing compute power, and a supportive investment climate, the market is set for exponential growth. As generative AI tools mature and regulatory clarity improves, they will become an integral part of the healthcare ecosystem enhancing efficiency, improving outcomes, and delivering more personalized care.

Looking For A Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=generative-ai-in-healthcare-market

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Related Reports:

AI in Mental Health Market

AI in Precision Medicine Market

Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.